PATENT CLAIM ANALYSIS

Application Number: 16040959
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-04
Patent Classification: ["424", "474000"]

Abstract:
Disclosed are pharmaceutical compositions having an effective amount of substantially amorphous ledipasvir and an effective amount of substantially crystalline sofosbuvir.

Claim (Index 16):
The method of  claim 12 , wherein the pharmaceutical composition is administered for about 6 weeks or less.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.3125
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15393847', '15885630', '15670283', '15282128', '14676370']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7204907834972921
- 35 USC 102 Novelty (BERT): 0.5710396371264966
- Combined Prediction Score: 0.7055456688602126
- Mean Citation Score: 296.9723180000001
- Max Citation Score: 455.52945
- Similarity Product: 409.2339502394021

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test